{"FsPickler":"0.9.6","type":"System.String","value":"@article{Levendo_lu_2004,\n\tdoi = {10.1097/01.brs.0000112068.16108.3a},\n\turl = {http://dx.doi.org/10.1097/01.brs.0000112068.16108.3a},\n\tyear = 2004,\n\tmonth = {apr},\n\tpublisher = {Ovid Technologies (Wolters Kluwer Health)},\n\tvolume = {29},\n\tnumber = {7},\n\tpages = {743--751},\n\tauthor = {Funda Levendo{\\u{g}}lu and Cemile Ã. Ã{\\u{g}}Ã¼n and Ãnder Ãzerbil and Tun{\\c{c}} C. Ã{\\u{g}}Ã¼n and Hatice U{\\u{g}}urlu},\n\ttitle = {Gabapentin Is a First Line Drug for the Treatment of Neuropathic Pain in Spinal Cord Injury},\n\tjournal = {Spine}\n}"}